Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women
Launched by UNIVERSITY HOSPITAL, LINKOEPING · Oct 11, 2024
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aim The primary aim of the current study is to evaluate the effects of dietary nutritional advice with regards to iron rich food sources or a daily oral supplement of 100 mg ferrous iron succinate in 80 menstruating, healthy women aged 20-40 years.
Methods The study will use a randomized controlled non-blinded design, and 80 healthy women aged 20-40 years whom regularly exercise will be included. Data collection will be made through online, standardized forms using the digital platform REDCap 13.1.28 (Vanderbilt University, Nashville, TN, USA). Study personnel will register laboratory and ...
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria: Inclusion criteria will be menstruating women aged 20 to 40 years who are healthy and regularly exercise.
- • -
- • Exclusion Criteria: Significant disease affecting inflammation and/or hemoglobin levels. Inability to cooperate or to fill out questionnaires.
- • -
About University Hospital, Linkoeping
The University Hospital in Linköping is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal institution within the region, it integrates cutting-edge medical practices with academic excellence, facilitating a collaborative environment for healthcare professionals and researchers. The hospital actively participates in a wide range of clinical trials across various medical disciplines, aiming to enhance patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and patient safety, the University Hospital in Linköping is dedicated to pioneering solutions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linköping, , Sweden
Patients applied
Trial Officials
Fredrik H Nyström, MD PhD Professor
Principal Investigator
Linkoeping University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported